Abiraterone Acetate, Prednisone, and Apalutamide in Treating Patients With Hormone-Naive Metastatic Prostate Cancer

NCT03821792 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Prostate Carcinoma
Prostate Adenocarcinoma
Prostate Carcinoma Metastatic in the Bone
Stage IV Prostate Cancer AJCC v8
Stage IVA Prostate Cancer AJCC v8
Stage IVB Prostate Cancer AJCC v8

Interventions

DRUG: Abiraterone Acetate
DRUG: Apalutamide
DRUG: Prednisone

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]